Associations Between Drug Burden Index, Medication Appropriateness and Patient-Reported Outcomes in the Community Pharmacy Setting in Malaysia

Syed Shahzad Hasan, Annita Shi Chin Liew, David Weng Kwai Chong, Kaeshaelya Thiruchelvam, Zaheer Ud Din Babar

Research output: Contribution to journalArticle

Abstract

Introduction: The increasing complexity of drug regimens over time and the use of multiple medications exposes older patients to a greater risk of receiving inappropriate medications. This study investigated whether Drug Burden Index (DBI) and potentially inappropriate medications (PIMs) were associated with patient-reported health outcomes (PROs) in community-dwelling older adults (aged ≥ 60 years) in Malaysia. Methods: DBI was used to quantify patients’ exposure to anticholinergic and sedative medications in a cross-sectional sample of older individuals from the community pharmacy setting in Malaysia. PIMs (based on Beers criteria), potentially inappropriate prescribing (PIP; based on STOPP criteria) and polypharmacy (use of ≥ 5 concurrent medications) were used to quantify exposure to inappropriate medications. PROs were investigated using the Groningen Frailty Indicator (GFI) for frailty and older people’s quality of life-35 (OPQOL) for quality of life (QOL). The adjusted associations between DBI, medication inappropriateness and PROs were analyzed. Results: More than half of the study participants received ≥ 1 anticholinergic or sedative medications (mean 0.47/participant; range 0.0–2.14). Prevalence of frailty was low (8.90% of patients), with a mean GFI score of 1.67 (range 1–8) and was significantly and positively correlated with DBI (r 0.253; p = 0.003). In multivariate logistic regression, frailty was found to be significantly associated with the odds of receiving DBI-associated medications (odds ratio 1.44; 95% CI 1.02–2.02, p = 0.039). Non-significant associations were found between DBI and QOL domains, except for a significant and positive correlation between the independence domain of OPQOL and PIP. Conclusion: This study indicates a significant relationship between drug burden measured by DBI and frailty measured by GFI. The prescribers managing various medical conditions of older people should consider frailty and other relevant physical health parameters as important health outcomes.

LanguageEnglish
Pages437-443
Number of pages7
JournalDrugs and Therapy Perspectives
Volume34
Issue number9
Early online date25 May 2018
DOIs
Publication statusPublished - 1 Sep 2018

Fingerprint

Pharmacies
Malaysia
Pharmaceutical Preparations
Quality of Life
Health
Cholinergic Antagonists
Hypnotics and Sedatives
Inappropriate Prescribing
Independent Living
Potentially Inappropriate Medication List
Patient Reported Outcome Measures
Polypharmacy
Logistic Models
Odds Ratio

Cite this

@article{df95dbc7c9d44efe8686e4d7e3cd257d,
title = "Associations Between Drug Burden Index, Medication Appropriateness and Patient-Reported Outcomes in the Community Pharmacy Setting in Malaysia",
abstract = "Introduction: The increasing complexity of drug regimens over time and the use of multiple medications exposes older patients to a greater risk of receiving inappropriate medications. This study investigated whether Drug Burden Index (DBI) and potentially inappropriate medications (PIMs) were associated with patient-reported health outcomes (PROs) in community-dwelling older adults (aged ≥ 60 years) in Malaysia. Methods: DBI was used to quantify patients’ exposure to anticholinergic and sedative medications in a cross-sectional sample of older individuals from the community pharmacy setting in Malaysia. PIMs (based on Beers criteria), potentially inappropriate prescribing (PIP; based on STOPP criteria) and polypharmacy (use of ≥ 5 concurrent medications) were used to quantify exposure to inappropriate medications. PROs were investigated using the Groningen Frailty Indicator (GFI) for frailty and older people’s quality of life-35 (OPQOL) for quality of life (QOL). The adjusted associations between DBI, medication inappropriateness and PROs were analyzed. Results: More than half of the study participants received ≥ 1 anticholinergic or sedative medications (mean 0.47/participant; range 0.0–2.14). Prevalence of frailty was low (8.90{\%} of patients), with a mean GFI score of 1.67 (range 1–8) and was significantly and positively correlated with DBI (r 0.253; p = 0.003). In multivariate logistic regression, frailty was found to be significantly associated with the odds of receiving DBI-associated medications (odds ratio 1.44; 95{\%} CI 1.02–2.02, p = 0.039). Non-significant associations were found between DBI and QOL domains, except for a significant and positive correlation between the independence domain of OPQOL and PIP. Conclusion: This study indicates a significant relationship between drug burden measured by DBI and frailty measured by GFI. The prescribers managing various medical conditions of older people should consider frailty and other relevant physical health parameters as important health outcomes.",
author = "Hasan, {Syed Shahzad} and Liew, {Annita Shi Chin} and Chong, {David Weng Kwai} and Kaeshaelya Thiruchelvam and Babar, {Zaheer Ud Din}",
year = "2018",
month = "9",
day = "1",
doi = "10.1007/s40267-018-0521-3",
language = "English",
volume = "34",
pages = "437--443",
journal = "Drugs and Therapy Perspectives",
issn = "1172-0360",
publisher = "Adis International Ltd",
number = "9",

}

Associations Between Drug Burden Index, Medication Appropriateness and Patient-Reported Outcomes in the Community Pharmacy Setting in Malaysia. / Hasan, Syed Shahzad; Liew, Annita Shi Chin; Chong, David Weng Kwai; Thiruchelvam, Kaeshaelya; Babar, Zaheer Ud Din.

In: Drugs and Therapy Perspectives, Vol. 34, No. 9, 01.09.2018, p. 437-443.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Associations Between Drug Burden Index, Medication Appropriateness and Patient-Reported Outcomes in the Community Pharmacy Setting in Malaysia

AU - Hasan, Syed Shahzad

AU - Liew, Annita Shi Chin

AU - Chong, David Weng Kwai

AU - Thiruchelvam, Kaeshaelya

AU - Babar, Zaheer Ud Din

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Introduction: The increasing complexity of drug regimens over time and the use of multiple medications exposes older patients to a greater risk of receiving inappropriate medications. This study investigated whether Drug Burden Index (DBI) and potentially inappropriate medications (PIMs) were associated with patient-reported health outcomes (PROs) in community-dwelling older adults (aged ≥ 60 years) in Malaysia. Methods: DBI was used to quantify patients’ exposure to anticholinergic and sedative medications in a cross-sectional sample of older individuals from the community pharmacy setting in Malaysia. PIMs (based on Beers criteria), potentially inappropriate prescribing (PIP; based on STOPP criteria) and polypharmacy (use of ≥ 5 concurrent medications) were used to quantify exposure to inappropriate medications. PROs were investigated using the Groningen Frailty Indicator (GFI) for frailty and older people’s quality of life-35 (OPQOL) for quality of life (QOL). The adjusted associations between DBI, medication inappropriateness and PROs were analyzed. Results: More than half of the study participants received ≥ 1 anticholinergic or sedative medications (mean 0.47/participant; range 0.0–2.14). Prevalence of frailty was low (8.90% of patients), with a mean GFI score of 1.67 (range 1–8) and was significantly and positively correlated with DBI (r 0.253; p = 0.003). In multivariate logistic regression, frailty was found to be significantly associated with the odds of receiving DBI-associated medications (odds ratio 1.44; 95% CI 1.02–2.02, p = 0.039). Non-significant associations were found between DBI and QOL domains, except for a significant and positive correlation between the independence domain of OPQOL and PIP. Conclusion: This study indicates a significant relationship between drug burden measured by DBI and frailty measured by GFI. The prescribers managing various medical conditions of older people should consider frailty and other relevant physical health parameters as important health outcomes.

AB - Introduction: The increasing complexity of drug regimens over time and the use of multiple medications exposes older patients to a greater risk of receiving inappropriate medications. This study investigated whether Drug Burden Index (DBI) and potentially inappropriate medications (PIMs) were associated with patient-reported health outcomes (PROs) in community-dwelling older adults (aged ≥ 60 years) in Malaysia. Methods: DBI was used to quantify patients’ exposure to anticholinergic and sedative medications in a cross-sectional sample of older individuals from the community pharmacy setting in Malaysia. PIMs (based on Beers criteria), potentially inappropriate prescribing (PIP; based on STOPP criteria) and polypharmacy (use of ≥ 5 concurrent medications) were used to quantify exposure to inappropriate medications. PROs were investigated using the Groningen Frailty Indicator (GFI) for frailty and older people’s quality of life-35 (OPQOL) for quality of life (QOL). The adjusted associations between DBI, medication inappropriateness and PROs were analyzed. Results: More than half of the study participants received ≥ 1 anticholinergic or sedative medications (mean 0.47/participant; range 0.0–2.14). Prevalence of frailty was low (8.90% of patients), with a mean GFI score of 1.67 (range 1–8) and was significantly and positively correlated with DBI (r 0.253; p = 0.003). In multivariate logistic regression, frailty was found to be significantly associated with the odds of receiving DBI-associated medications (odds ratio 1.44; 95% CI 1.02–2.02, p = 0.039). Non-significant associations were found between DBI and QOL domains, except for a significant and positive correlation between the independence domain of OPQOL and PIP. Conclusion: This study indicates a significant relationship between drug burden measured by DBI and frailty measured by GFI. The prescribers managing various medical conditions of older people should consider frailty and other relevant physical health parameters as important health outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85051724279&partnerID=8YFLogxK

U2 - 10.1007/s40267-018-0521-3

DO - 10.1007/s40267-018-0521-3

M3 - Article

VL - 34

SP - 437

EP - 443

JO - Drugs and Therapy Perspectives

T2 - Drugs and Therapy Perspectives

JF - Drugs and Therapy Perspectives

SN - 1172-0360

IS - 9

ER -